Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony C Arvanites

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Discovery|July 25, 2012
Virtual drug discovery: beyond computational chemistry?Francois Gilardoni, Anthony C Arvanites
Plos One|September 2, 2021
Synthetic modified Fezf2 mRNA (modRNA) with concurrent small molecule SIRT1 inhibition enhances refinement of cortical subcerebral/corticospinal neuron identity from mouse embryonic stem cellsCameron Sadegh, Wataru Ebina, Anthony C Arvanites, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 16, 2010
Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosisRadhia Benmohamed, Anthony C Arvanites, Jinho Kim, et al.
Bioorganic & Medicinal Chemistry|December 23, 2011
Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cellsWei Zhang, Radhia Benmohamed, Anthony C Arvanites, et al.
Bio-Protocol|May 15, 2023
Implementation of a Drug Screening Platform to Target<i>Gch1</i> Expression in Injured Mouse Dorsal Root Ganglion NeuronsShane J F Cronin, Lance S Davidow, Anthony C Arvanites, et al.
Journal of Medicinal Chemistry|March 8, 2011
Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosisGuoyao Xia, Radhia Benmohamed, Jinho Kim, et al.
ACS Chemical Biology|May 5, 2012
Selective identification of hedgehog pathway antagonists by direct analysis of smoothened ciliary translocationYu Wang, Anthony C Arvanites, Lance Davidow, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosisTian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replicationJustin P Annes, Jennifer Hyoje Ryu, Kelvin Lam, et al.
Elife|September 19, 2014
Reversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathwayBarak Blum, Adam N Roose, Ornella Barrandon, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|July 25, 2012
Virtual drug discovery: beyond computational chemistry?Francois Gilardoni, Anthony C Arvanites
Plos One|September 2, 2021
Synthetic modified Fezf2 mRNA (modRNA) with concurrent small molecule SIRT1 inhibition enhances refinement of cortical subcerebral/corticospinal neuron identity from mouse embryonic stem cellsCameron Sadegh, Wataru Ebina, Anthony C Arvanites, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 16, 2010
Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosisRadhia Benmohamed, Anthony C Arvanites, Jinho Kim, et al.
Bioorganic & Medicinal Chemistry|December 23, 2011
Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cellsWei Zhang, Radhia Benmohamed, Anthony C Arvanites, et al.
Bio-Protocol|May 15, 2023
Implementation of a Drug Screening Platform to Target<i>Gch1</i> Expression in Injured Mouse Dorsal Root Ganglion NeuronsShane J F Cronin, Lance S Davidow, Anthony C Arvanites, et al.
Journal of Medicinal Chemistry|March 8, 2011
Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosisGuoyao Xia, Radhia Benmohamed, Jinho Kim, et al.
ACS Chemical Biology|May 5, 2012
Selective identification of hedgehog pathway antagonists by direct analysis of smoothened ciliary translocationYu Wang, Anthony C Arvanites, Lance Davidow, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosisTian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replicationJustin P Annes, Jennifer Hyoje Ryu, Kelvin Lam, et al.
Elife|September 19, 2014
Reversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathwayBarak Blum, Adam N Roose, Ornella Barrandon, et al.
Pageof 2